Procena vrednosti selektivne disekcije vrata u terapiji bolesnika sa karcinomima farinksne i oralne regije
The estimation of value of selective neck dissection in the treatment of patients with carcinomas pharyngeal and oral localisation
Author
Trivić, Aleksandar S.Mentor
Petrović, ŽeljkoCommittee members
Đukić, VojkoMilovanović, Jovica

Kosanović, Rade
Metadata
Show full item recordAbstract
Skoro se navršilo sto godina od kada je zaslugom George Crile-a opisana
sistematska ekscizija cervikalnih limfonodusa u cilju hirurškog lečenja bolesnika sa
karcinomima glave i vrata. George Crile je 1906. godine opisao operaciju koju je nazvao
"radikalna disekcija vrata", zasnovanu na sopstvenom iskustvu i studiji impozantne serije
4500 bolesnika s karcinomima glave i vrata koji su umrli zbog primarnog tumora ili
regionalnih metastaza u vratu i samo 1% zbog udaljenih metastaza.
Radikalna disekcija vrata vremenom postaje gotovo standardna procedura za
bolesnike kojima je bio potreban hirurški tretman metastatskih depozita u kombinaciji sa
uklanjanjem primarnog tumora. U međuvremenu, svima koji su bili angažovani u lečenju
bolesnika s karcinomom glave i vrata postalo je jasno da je radikalna disekcija vrata
adekvatna u tretiranju velikih palpabilnih limfonodusa, ali i preterano agresivna kako na
pacijentima s malim palpabilnim limfonodusima, i naročito na onima bez palpabilnih
limfonodu...sa ili sa visokim rizikom metastaziranja.
Modifikovana radikalna disekcija (MRDV) uklanja "en bloc" iste limfonoduse i
limfatike kao i radikalna disekcija, ali očuvanjem jedne ili više nelimfatičkih struktura koje
se rutinski uklanjaju radikalnom disekcijom, smanjuje postoperativni morbiditet. Još dalje
se otišlo selektivnim disekcijama (SDV) koje preferiraju američki hirurzi glave i vrata.
Operacije uključuju selektivno uklanjanje pojedinih grupa limfonodusa sa rizikom
metastaze i očuvanje svih nelimfatičkih struktura i preostalih grupa nodusa u slučajevima
nodus negativnog vrata. Zagovara se njena primena i u slučajevima nodus pozitivnog vrata.
Ovde vladaju velike kontroverze posebno kada je u pitanju grupa bolesnika sa evidentnim
metastatskim depozitima u vratu...
There has recently been one hundred years since George Crile demonstrated
systematic cervical lymph nodes excision for treatment of patients with head and neck
carcinoma. In 1906, George Crile has described surgical operation he called “radical neck
dissection”, based on his previous experience and a study of impressive group of 4.500
patients with head and neck carcinoma.
Over time, radical neck dissection has became almost standard procedure for
patients who required surgical treatment of metastatic deposits combined with primary
tumor removal. In the meantime, everyone involved in treatment of patients with head and
neck carcinoma began to understand that the radical neck dissection was adequate for
treating large palpable lymph nodes, but that it was excessively aggressive in both patients
with small palpable lymph nodes, and especially those without palpable lymph nodes or
with high risk of metastases.
Modified radical neck dissection (MRND) removes “en block” the same lymph
nodes... and vessels as radical dissection, but by preserving one or more non-lymphatic
structures that are being radically removed by radical dissection it decreases postoperative
morbidity. Selective neck dissections, which are being preferred by American head and
neck surgeons, went even further. Operations include selective removal of individual
groups of lymph nodes with risk of metastases and preservation of all non-lymphatic
structures and remaining groups of lymph nodes in cases of node-negative neck. It use in
cases of node-positive neck is being advocated as well. There are large controversies in this
area, especially in patients with evident metastatic neck deposits.
The research was performed at Clinic for Otolaryngology and Maxillofacial Surgery
of Clinical Center of Serbia in Belgrade. The study included 608 patients treated over a ten year period, from January 1, 1992 to December 31, 2001, who have been followed up for at
least 5 years after administered treatment...